Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1376 clinical trials
OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)

This is a prospective study of a new generation of drug-eluting stent in the treatment of non ST elevation acute coronary syndrome (NSTE-ACS). The purpose of this study was to evaluate the extent of early vascular repair in NSTE-ACS patients after receiving the new generation of drug-eluting stents, and the …

bypass surgery
dapt
neointima
myocardial infarction
acute coronary syndrome
  • 0 views
  • 19 Feb, 2024
  • 2 locations
A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

A study of CT-RD06 cell injection in patients with relapsed or refractory CD19+ B-cell hematological malignancy.

oxygen saturation
chronic lymphocytic leukemia
flow cytometry
cancer
leukemia
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

A study of CTA101 UCAR-T cell injection in patients with relapsed or refractory CD19+ B-line hematological malignancy

autologous hematopoietic stem cell transplant
oxygen saturation
chronic lymphocytic leukemia
flow cytometry
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Microbiome and Rectal Cancer

The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.

chemoradiotherapy
adenocarcinoma
cancer
adjuvant therapy
neoadjuvant therapy
  • 0 views
  • 19 Feb, 2024
  • 3 locations
LYT-100 in Healthy Volunteers and BCRL

Part 1 is a multiple ascending dose trial in healthy volunteers (HV) of LYT-100 to determine safety, tolerability, and pharmacokinetic (PK) profile under fed conditions. Part 2 is a single dose safety, tolerability, and PK trial in HV of LYT-100 under fasted conditions. Part 3 is a trial of up …

nipple reconstruction
carcinoma
reconstructive surgery
secondary lymphedema
adjuvant
  • 0 views
  • 19 Feb, 2024
  • 1 location
Empowering Patients to Participate in Health Care Decisions

The study aims to evaluate whether an intervention with patient education in study circles, aiming to empower patients to participate in health care an rehabilitation by increasing health literacy and sense of coherence, may have a causal effect on perceived health, ability and function as well as independence and quality …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients

bcma
multiple myeloma
cellular therapy
lenalidomide
dexamethasone
  • 0 views
  • 19 Feb, 2024
  • 1 location
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

This is a prospective non-blinded randomized control pilot study comparing the effect of pulmonary vein isolation against medical management of atrial fibrillation in patients with Heart Failure with preserved Ejection Fraction (HFpEF).

natriuretic peptide
ventricular hypertrophy
b-type natriuretic peptide
fibrillation
cardioversion
  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy of Iodine Complex Against COVID-19 Patients

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

SARS
acute respiratory syndrome (sars)
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

bisphosphonate
central nervous system disorder
alopecia
invasive breast cancer
aptt
  • 8 views
  • 19 Feb, 2024
  • 1 location